SmartTab’s CEO, Robert Niichel, will present at the INNOV8 Talks’ pitch competition at the Arab Health 2021 conference in Dubai on May 31st. The company presented its drug delivery platform, the InjectTab™, TargetTab™, and MultiTab™, to a panel of judges, investors, and executives for global health companies like Philips and GE Healthcare. Arab Health saw over 55,000 attendees at last years’ event. SmartTab will be in the Startup Exhibit area to meet with potential partners throughout the week as well.
The Innov8 Talks, hosts 8 pitches, 8-minutes long, across each day of Arab Health. With a theme focused on innovation in healthcare, the INNOV8 Talks pitch competition at the Arab Health 2021 conference in Dubai is highly competitive. It received over 7,000 applications, and just eight companies got selected to present for each day of the conference. SmartTab presents on round three, Monday, May 31st. The judging panel from each day will select a winner, and the top four will go head-to-head in the finals. Niichel will present the SmartTab Drug Delivery Platform, which is comprised of an ingestible capsule with a microprocessor, proprietary smart polymer actuator, and active ingredients.
“I am proud to represent SmartTab on the global stage to share about our global wireless drug delivery revolution. This is one of the world’s largest medical conferences, and I’m ecstatic we will be featured in the Innov8 Talks to connect with partners all over the globe”
Robert Niichel, Founder and CEO, SmartTab
Innovation will rapidly change healthcare’s approach to prevention, technology-enabled care, personalized care, better health outcomes, and cost effectiveness. Efficiency with artificial intelligence, virtual reality, and blockchain within digital health are disrupting patient care with innovation.
SmartTab boldly combines wireless ingestible technology with active ingredient delivery. We are pioneering pharmaceutical delivery technologies that will transform the way we take medication. SmartTab has two products that are destined to be life-changing for millions of patients suffering from Crohn’s Disease and other gastrointestinal diseases: TargetTab™—a pill that you can tell when and where it releases medication in your body and InjectTab™—a pill to deliver biologics and large molecule without a visit to the doctor.